Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis.

ABSTRACT: Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.

SUBMITTER: Bloemberg GV 

PROVIDER: S-EPMC4681277 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature